NIAID Banner Logo Image

Opportunistic Infections Citation List: June 21 - July 4, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Isolation and Characterization of a Proteinaceous Antifungal Compound from Lactobacillus plantarum YML007 and Its Application as a Food Preservative. Ahmad Rather, I., B.J. Seo, V.J. Rejish Kumar, U.H. Choi, K.H. Choi, J.H. Lim, and Y.H. Park. Letters in Applied Microbiology, 2013. 57(1): p. 69-76. PMID[23565693].

[PubMed]. OI_0621-070413.


2. Effects of Amphotericin B on Aspergillus flavus Clinical Isolates with Variable Susceptibilities to the Polyene in an Experimental Model of Systemic Aspergillosis. Barchiesi, F., E. Spreghini, M. Sanguinetti, D. Giannini, E. Manso, P. Castelli, and C. Girmenia. The Journal of Antimicrobial Chemotherapy, 2013. [Epub ahead of print]. PMID[23794598].

[PubMed]. OI_0621-070413.


3.Search for a Potent Microbicidal Spermicide from the Isolates of Shorea robusta Resin. Bharitkar, Y.P., M. Banerjee, S. Kumar, R. Paira, R. Meda, K. Kuotsu, and N.B. Mondal. Contraception, 2013. 88(1): p. 133-140. PMID[23290431].

[PubMed]. OI_0621-070413.


4. Amphotericin B-Copper(II) Complex as a Potential Agent with Higher Antifungal Activity against Candida albicans.Chudzik, B., I. Tracz, G. Czernel, M. Fiolka, G. Borsuk, and M. Gagos. European Journal of Pharmaceutical Sciences, 2013. [Epub ahead of print]. PMID[23791641].

[PubMed]. OI_0621-070413.


5. Isavuconazole Activity against Emerging Fungal Pathogens with Reduced Azole-susceptibility: Aspergillus lentulus, Neosartorya udagawae and Cryptococcus gattii. Datta, K., P. Rhee, E. Byrnes, 3rd, G. Garcia-Effron, D.S. Perlin, J.F. Staab, and K.A. Marr. Journal of Clinical Microbiology, 2013. [Epub ahead of print]. PMID[23804388].

[PubMed]. OI_0621-070413.


6. Antifungal Activity of the Non Cytotoxic Human Peptide Hepcidin 20 against Fluconazole Resistant Candida glabrata in Human Vaginal Fluid. Del Gaudio, G., L. Lombardi, G. Maisetta, S. Esin, G. Batoni, M. Sanguinetti, S. Senesi, and A. Tavanti. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23796919].

[PubMed]. OI_0621-070413.


8. Antifungal Activities of Diphenyl diselenide Alone and in Combination with Fluconazole or Amphotericin B against Candida glabrata.Denardi, L.B., D.A. Mario, E.S. de Loreto, C.W. Nogueira, J.M. Santurio, and S.H. Alves. Mycopathologia, 2013. [Epub ahead of print]. PMID[23793863].

[PubMed]. OI_0621-070413.


9. Antifungal and Anticancer Effects of a Polysaccharide-protein Complex from the Gut Bacterium Raoultella ornithinolytica Isolated from the Earthworm Dendrobaena veneta. Fiolka, M.J., K. Lewtak, J. Rzymowska, K. Grzywnowicz, M. Hulas-Stasiak, W. Sofinska-Chmiel, and K. Skrzypiec. Pathogens and Disease, 2013. [Epub ahead of print]. PMID[23794449].

[PubMed]. OI_0621-070413.


10. KB425796-A, a Novel Antifungal Antibiotic Produced by Paenibacillus sp. 530603. Kai, H., M. Yamashita, S. Takase, M. Hashimoto, H. Muramatsu, I. Nakamura, K. Yoshikawa, M. Ezaki, K. Nitta, M. Watanabe, N. Inamura, and A. Fujie. The Journal of Antibiotics, 2013. [Epub ahead of print]. PMID[23778117].

[PubMed]. OI_0621-070413.


11. Identification of Ten KB425796-A Congeners from Paenibacillus sp. 530603 Using an Antifungal Assay against Aspergillus fumigatus in Combination with Micafungin. Kai, H., M. Yamashita, S. Takase, M. Hashimoto, H. Muramatsu, I. Nakamura, K. Yoshikawa, R. Kanasaki, M. Ezaki, K. Nitta, M. Watanabe, N. Inamura, and A. Fujie. The Journal of Antibiotics, 2013. [Epub ahead of print]. PMID[23778114].

[PubMed]. OI_0621-070413.


12. Antimicrobial Activity of the Synthetic Peptide Scolopendrasin II from the Centipede Scolopendra subspinipes mutilans. Kwon, Y.N., J.H. Lee, I.W. Kim, S.H. Kim, E.Y. Yun, S.H. Nam, M.Y. Ahn, M. Jeong, D.C. Kang, I.H. Lee, and J.S. Hwang. Journal of Microbiology and Biotechnology, 2013. [Epub ahead of print]. PMID[23801249].

[PubMed]. OI_0621-070413.


13. Antimicrobial Efficacy of Liposome-encapsulated Silver Ions and Tea Tree Oil against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans. Low, W.L., C. Martin, D.J. Hill, and M.A. Kenward. Letters in Applied Microbiology, 2013. 57(1): p. 33-39. PMID[23581401].

[PubMed]. OI_0621-070413.


14. Antimicrobial Activity of Southern African Medicinal Plants with Dermatological Relevance: From an Ethnopharmacological Screening Approach, to Combination Studies and the Isolation of a Bioactive Compound. Mabona, U., A. Viljoen, E. Shikanga, A. Marston, and S. Van Vuuren. Journal of Ethnopharmacology, 2013. 148(1): p. 45-55. PMID[23545456].

[PubMed]. OI_0621-070413.


15. Evaluation of the Correlation of Caspofungin MICs and Treatment Outcome in Murine Infections by Wild Type Strains of Candida parapsilosis. Salas, V., F.J. Pastor, J. Capilla, D.A. Sutton, E. Mayayo, A.W. Fothergill, M.G. Rinaldi, and J. Guarro. Diagnostic Microbiology and Infectious Disease, 2013. [Epub ahead of print]. PMID[23806662]

[PubMed]. OI_0621-070413.


16. Efficacy of Amphotericin B at Suboptimal Dose Combined with Voriconazole in a Murine Infection by Aspergillus fumigatus with Poor in Vivo Response to the Azole. Sandoval-Denis, M., F.J. Pastor, J. Capilla, and J. Guarro. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23796928].

[PubMed]. OI_0621-070413.


17. Antifungal Efficacy of Some Natural Phenolic Compounds against Significant Pathogenic and Toxinogenic Filamentous Fungi. Zabka, M. and R. Pavela. Chemosphere, 2013. [Epub ahead of print]. PMID[23800587].

[PubMed]. OI_0621-070413.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

18. Detection of Inhibitors of Phenotypically Drug-tolerant Mycobacterium tuberculosis Using an in Vitro Bactericidal Screen. Bassett, I.M., S. Lun, W.R. Bishai, H. Guo, J.R. Kirman, M. Altaf, and R.F. O'Toole. Journal of Microbiology, 2013. [Epub ahead of print]. PMID[23800952].

[PubMed]. OI_0621-070413.


19. Synthesis of Chromone, Quinolone, and Benzoxazinone Sulfonamide Nucleosides as Conformationally Constrained Inhibitors of Adenylating Enzymes Required for Siderophore Biosynthesis. Engelhart, C.A. and C.C. Aldrich. The Journal of Organic Chemistry, 2013. [Epub ahead of print]. PMID[23805993].

[PubMed]. OI_0621-070413.


20. Transition Metal-alpha-amino acid Complexes with Antibiotic Activity against Mycobacterium spp. Karpin, G.W., J.S. Merola, and J.O. Falkinham, 3rd. Antimicrobial Agents and Chemotherapy, 2013. 57(7): p. 3434-3436. PMID[23650159].

[PubMed]. OI_0621-070413.


21. Synthesis and 3D-QSAR Analysis of 2-Chloroquinoline Derivatives as H37RV MTB Inhibitors. Khunt, R.C., V.M. Khedkar, and E.C. Coutinho. Chemical Biology & Drug Design, 2013. [Epub ahead of print]. PMID[23790070].

[PubMed]. OI_0621-070413.


22. Growth-inhibitory Activity of Natural and Synthetic Isothiocyanates against Representative Human Microbial Pathogens. Kurepina, N., B.N. Kreiswirth, and A. Mustaev. Journal of Applied Microbiology, 2013. [Epub ahead of print]. PMID[23789822].

[PubMed]. OI_0621-070413.


23. Radiologic Responses in Cynomolgous Macaques for Assessing Tuberculosis Chemotherapy Regimens. Lin, P.L., T. Coleman, J.P. Carney, B.J. Lopresti, J. Tomko, D. Fillmore, V. Dartois, C. Scanga, L.J. Frye, C. Janssen, E. Klein, C.E. Barry, 3rd, and J.L. Flynn. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23796926].

[PubMed]. OI_0621-070413.


24. A Novel Quinoline Derivative That Inhibits Mycobacterial FtsZ. Mathew, B., L. Ross, and R.C. Reynolds. Tuberculosis, 2013. 93(4): p. 398-400. PMID[23647650].

[PubMed]. OI_0621-070413.


25. Antimycobacterial Activity of Citrullus colocynthis (L.) Schrad. against Drug Sensitive and Drug Resistant Mycobacterium. tuberculosis and MOTT Clinical Isolates. Mehta, A., G. Srivastva, S. Kachhwaha, M. Sharma, and S.L. Kothari. Journal of Ethnopharmacology, 2013. [Epub ahead of print]. PMID[23816500].

[PubMed]. OI_0621-070413.


26. Diarylcoumarins Inhibit Mycolic acid Biosynthesis and Kill Mycobacterium tuberculosis by Targeting FadD32. Stanley, S.A., T. Kawate, N. Iwase, M. Shimizu, A.E. Clatworthy, E. Kazyanskaya, J.C. Sacchettini, T.R. Ioerger, N.A. Siddiqi, S. Minami, J.A. Aquadro, S. Schmidt Grant, E.J. Rubin, and D.T. Hung. Proceedings of the National Academy of Sciences of the United States of America, 2013. [Epub ahead of print]. PMID[23798446].

[PubMed]. OI_0621-070413.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

27. In Vivo Antimalarial Activity of Keetia leucantha Twigs Extracts and in Vitro Antiplasmodial Effect of Their Constituents. Bero, J., M.F. Herent, G. Schmeda-Hirschmann, M. Frederich, and J. Quetin-Leclercq. Journal of Ethnopharmacology, 2013. [Epub ahead of print]. PMID[23792125].

[PubMed]. OI_0621-070413.


28. In Silico Screening on the Three-dimensional Model of the Plasmodium vivax SUB1 Protease Leads to the Validation of a Novel Anti-parasite Compound. Bouillon, A., D. Giganti, C. Benedet, O. Gorgette, S. Petres, E. Crublet, C. Girard-Blanc, B. Witkowski, D. Menard, M. Nilges, O. Mercereau-Puijalon, V. Stoven, and J.C. Barale. The Journal of Biological Chemistry, 2013. 288(25): p. 18561-18573. PMID[23653352].

[PubMed]. OI_0621-070413.


29. Chemical and Genetic Validation of Thiamine Utilization as an Antimalarial Drug Target. Chan, X.W., C. Wrenger, K. Stahl, B. Bergmann, M. Winterberg, I.B. Muller, and K.J. Saliba. Nature Communications, 2013. 4: p. 2060. PMID[23804074].

[PubMed]. OI_0621-070413.


30. In Vitro and in Vivo Antimalarial Efficacies of Optimized Tetracyclines. Draper, M.P., B. Bhatia, H. Assefa, L. Honeyman, L.K. Garrity-Ryan, A.K. Verma, J. Gut, K. Larson, J. Donatelli, A. Macone, K. Klausner, R.G. Leahy, A. Odinecs, K. Ohemeng, P.J. Rosenthal, and M.L. Nelson. Antimicrobial Agents and Chemotherapy, 2013. 57(7): p. 3131-3136. PMID[23629719].

[PubMed]. OI_0621-070413.


31. In Vivo Antimalarial Activity of Trichilia megalantha Harms Extracts and Fractions in Animal Models. Fadare, D.A., O.O. Abiodun, and E.O. Ajaiyeoba. Parasitology Research, 2013. [Epub ahead of print]. PMID[23801363].

[PubMed]. OI_0621-070413.


32. HIV Treatments Have Malaria Gametocyte Killing and Transmission Blocking Activity. Hobbs, C.V., T.Q. Tanaka, O. Muratova, J. Van Vliet, W. Borkowsky, K.C. Williamson, and P.E. Duffy. The Journal of Infectious Diseases, 2013. 208(1): p. 139-148. PMID[23539746].

[PubMed]. OI_0621-070413.


33. Potential of Lichen Secondary Metabolites against Plasmodium Liver Stage Parasites with FAS-II as the Potential Target. Lauinger, I.L., L. Vivas, R. Perozzo, C. Stairiker, A. Tarun, M. Zloh, X. Zhang, H. Xu, P.J. Tonge, S.G. Franzblau, D.H. Pham, C.V. Esguerra, A.D. Crawford, L. Maes, and D. Tasdemir. Journal of Natural Products, 2013. 76(6): p. 1064-1070. PMID[23806111].

[PubMed]. OI_0621-070413.


34. Falcipain-2 Inhibition by Suramin and Suramin Analogues. Marques, A.F., D. Esser, P.J. Rosenthal, M.U. Kassack, and L.M. Lima. Bioorganic & Medicinal Chemistry, 2013. 21(13): p. 3667-3673. PMID[23680445].

[PubMed]. OI_0621-070413.


35. Effect of Chloroquine, Methylene Blue and Artemether on Red Cell and Hepatic Antioxidant Defence System in Mice Infected with Plasmodium yoelii nigeriensis. Nneji, C.M., O.A. Adaramoye, C.O. Falade, and O.G. Ademowo. Parasitology Research, 2013. 112(7): p. 2619-2625. PMID[23604568].

[PubMed]. OI_0621-070413.


36. Synthesis and Antiprotozoal Activity of Dicationic m-Terphenyl and 1,3-Dipyridylbenzene Derivatives. Patrick, D.A., M.A. Ismail, R.K. Arafa, T. Wenzler, X. Zhu, T. Pandharkar, S.K. Jones, K.A. Werbovetz, R. Brun, D.W. Boykin, and R.R. Tidwell. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23795673].

[PubMed]. OI_0621-070413.


37. Bioactive Compounds from the Roots of Strophioblachia fimbricalyx. Seephonkai, P., S.G. Pyne, A.C. Willis, and W. Lie. Journal of Natural Products, 2013. [Epub ahead of print]. PMID[23806014].

[PubMed]. OI_0621-070413.


38. Antimalarial Activity of Bergenia ciliata (Haw.) Sternb. against Plasmodium berghei. Walter, N.S., U. Bagai, and S. Kalia. Parasitology Research, 2013. [Epub ahead of print]. PMID[23793360].

[PubMed]. OI_0621-070413.

Citations from the ISI Web of Knowledge Listings for O.I.

39. N '- 4- (Substituted imino)methyl benzylidene -substituted benzohydrazides: Synthesis, Antimicrobial, Antiviral, and Anticancer Evaluation, and QSAR Studies. Kumar, P., B. Narasimhan, K. Ramasamy, V. Mani, R.K. Mishra, A.A. Majeed, and E. De Clercq. Monatshefte fur Chemie, 2013. 144(6): p. 825-849. ISI[000318870600010].

[WOS]. OI_0621-070413.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2022